Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol

S. M. Cohen, A. M. Saulenas, C. R. Sullivan, Daniel Albert

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.

Original languageEnglish (US)
Pages (from-to)541-543
Number of pages3
JournalArchives of Ophthalmology
Volume106
Issue number4
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Retinoblastoma
Calcitriol
Vitamin D
Neoplasms
Poisons
Nude Mice
Antineoplastic Agents
Necrosis
Growth

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol. / Cohen, S. M.; Saulenas, A. M.; Sullivan, C. R.; Albert, Daniel.

In: Archives of Ophthalmology, Vol. 106, No. 4, 01.01.1988, p. 541-543.

Research output: Contribution to journalArticle

@article{8aaef4a543ca469fb984cf148b56c2be,
title = "Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol",
abstract = "We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.",
author = "Cohen, {S. M.} and Saulenas, {A. M.} and Sullivan, {C. R.} and Daniel Albert",
year = "1988",
month = "1",
day = "1",
doi = "10.1001/archopht.1988.01060130587043",
language = "English (US)",
volume = "106",
pages = "541--543",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol

AU - Cohen, S. M.

AU - Saulenas, A. M.

AU - Sullivan, C. R.

AU - Albert, Daniel

PY - 1988/1/1

Y1 - 1988/1/1

N2 - We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.

AB - We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.

UR - http://www.scopus.com/inward/record.url?scp=0023936074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023936074&partnerID=8YFLogxK

U2 - 10.1001/archopht.1988.01060130587043

DO - 10.1001/archopht.1988.01060130587043

M3 - Article

C2 - 3355424

AN - SCOPUS:0023936074

VL - 106

SP - 541

EP - 543

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 4

ER -